Accessibility: Skip TopNav
Figure 1: CX-2029 Spider Plot: Phase 1 Dose Escalation Study (2-5 mg/kg)
* Denotes subject who is considered to be on treatment, as no End of Treatment date is in the database.
Format
PNG
Source
CytomX Therapeutics Inc.
Downloads
Original
Large
Medium
Small